Zhejiang Longsheng Group Co.,Ltd (600352.SS): BCG Matrix [Apr-2026 Updated]

Zhejiang Longsheng's portfolio is powered by high-growth stars-chemical intermediates, the Dystar acquisition and specialty chemicals-that warrant continued reinvestment, while massive dye and additives cash cows generate the steady cash needed to fund expansion; meanwhile volatile question marks (real estate and nascent EV-chemicals) demand selective capital and clear exit/scale criteria, and small-scale dogs (auto parts, basic inorganics, miscellaneous services) should be considered for divestment to sharpen focus and improve ROIC.

Zhejiang Longsheng Group Co.,Ltd (600352.SS) - BCG Matrix Analysis: Stars

Stars

The high growth intermediates segment is a core Star for Zhejiang Longsheng, led by meta-phenylenediamine (MPD) and resorcinol production capacity of 119,500 tons annually. Sales volume for this segment rose 15.16% year-on-year during the first three quarters of 2024, reflecting strong demand from aramid fiber and rubber adhesive end-markets. The global dye and pigment intermediates market, forecasted to grow at a 4.75% CAGR through 2035 to an approximate USD 27.33 billion valuation, provides a favorable market backdrop for Longsheng's leading position. Despite deflationary pressures in basic dye pricing, this intermediates unit recorded positive revenue growth in both 2024 and 2025, and ongoing capex is being allocated to vertical integration and margin capture across the value chain.

The Dystar acquisition integration is a primary Star within Longsheng's portfolio, contributing 5.35 billion CNY in revenue in 2024 and acting as the highest-performing individual brand source for the group. Dystar's product mix has transitioned toward high-performance and eco-friendly textile chemicals, aligning with a global textile colorant market CAGR of approximately 5.0%. In H1 2025, units associated with Dystar and international operations contributed to a combined 49.26% of total group revenue, helping to offset a 6.47% consolidated revenue decline during the same period and sustaining a group gross margin of 28.61% attributable in part to Dystar's premium pricing.

Longsheng's advanced specialty chemicals portfolio constitutes another Star, targeting an estimated USD 691 billion global specialty chemicals market growing at a 5.68% CAGR through 2034. The specialty division accounted for approximately 86.30% of total group revenue in recent reporting periods, illustrating its dominance in the company's revenue mix. Focused on high-purity, application-specific formulations for electronics, pharmaceuticals and high-end industrial uses, this segment achieved a net income increase of 32.36% in fiscal 2024, demonstrating successful conversion of market growth into bottom-line expansion. Technological barriers, IP and formulation expertise bolster ROI and protect margins as the Asia-Pacific shift toward value-added chemical verticals accelerates.

• High-growth indicators: 15.16% Y/Y volume growth (intermediates), 5.35 billion CNY revenue from Dystar (2024), 32.36% net income growth (2024).
• Market tailwinds: intermediates CAGR 4.75% to 2035; textile colorant CAGR ~5.0%; specialty chemicals CAGR 5.68% to 2034.
• Revenue concentration: specialty chemicals = 86.30% of group revenue; Dystar + international ~49.26% contribution in H1 2025.
• Strategic capital allocation: capex to integrate intermediates supply chain, consolidation of Dystar stake (37.57%), R&D and purity-focused investments for specialty formulations.
• Financial resilience: segment-level positive revenue growth in 2024-2025 and maintained group gross margin of 28.61% despite macro headwinds.

Zhejiang Longsheng Group Co.,Ltd (600352.SS) - BCG Matrix Analysis: Cash Cows

Cash Cows

Dominant dye production capacity maintains a global leadership position with an annual output of 300,000 tons as of late 2024, accounting for over 50% of group income and serving as the primary source of the 9.265 billion CNY net operating cash flow reported in 2024. In a domestically oversupplied dye industry with low market growth (approx. 3.28% production volume growth), Longsheng's scale supports a stable 28.61% gross margin. The unit's high market share in a mature industry provides liquidity to fund a 0.25 CNY per share dividend and to underpin strategic moves into higher-growth chemical intermediates, while helping to absorb pressure from a current 13% quarterly operating income decline.

Established textile additives business operates with a 100,000-ton annual capacity and a top-tier global market ranking. Additives sales volumes rose 10.29% in the first nine months of 2024 despite intense price competition. This segment delivers consistent returns with minimal CAPEX needs and contributed to the 2.03 billion CNY net income attributable to shareholders in 2024. The mature customer base in printing and dyeing positions Longsheng as a preferred low-cost supplier; cash flow resilience from this unit supports the company's 10.47 CNY stock valuation and a 4.71% dividend yield as of December 2025.

Domestic China operations provide a stable revenue foundation, representing 9.08 billion CNY of total revenue in the most recent full fiscal year, up from 8.50 billion CNY the previous year. The domestic segment contributes the bulk of the 15.88 billion CNY total revenue and operates with predictable margins in the world's largest textile manufacturing hub. A 236.8% surge in operating cash flow underscores the efficiency of domestic operations in extracting value from a slow-growth environment. This stability supports a low equity beta of 0.50, indicating a highly reliable cash-generating core for the group.

Implications for portfolio management:

• Prioritize reinvestment of dye and additives cash flows into higher-growth chemical intermediates and R&D to counteract mature market stagnation.
• Maintain dividend policy (0.25 CNY/share) funded by dye cash generation while preserving buffer for cyclical downturns evidenced by the recent -13% quarterly operating income.
• Exploit additives' low CAPEX profile and rising sales volumes (10.29%) to sustain margins and fund selective bolt-on acquisitions.
• Continue optimizing domestic operations to preserve the 28.61% gross margin and capitalize on the 236.8% operating cash flow improvement.
• Monitor market pricing pressure and oversupply risks in dye markets; deploy cash reserves to diversify revenue mix and reduce reliance on a single mature product line.

Zhejiang Longsheng Group Co.,Ltd (600352.SS) - BCG Matrix Analysis: Question Marks

Question Marks - Dogs: Real estate development and new energy vehicle (NEV) chemical applications sit in ambiguous positions of the portfolio, exhibiting low-to-moderate relative market share amid divergent market growth rates. The real estate segment delivered an 87.26% revenue increase in fiscal 2024 driven by project sales, yet faced severe margin pressure and liquidity/regulatory constraints. NEV chemical applications are in an early-stage, high-growth market but currently contribute less than 2.0% of total revenue and require sustained R&D investment to scale.

Real estate development segment performance and impact:

Implications for real estate as a Question Mark/Dog:

• Short-term liquidity boost: Pre-sale receipts improved cash inflows in 2024 but are one-off and tied to project completion schedules.
• High CAPEX and COGS inflation: 93.76% COGS rise and a 2.42 percentage-point gross margin contraction reduced profitability and ROIC on the segment.
• Regulatory risk: Policy tightening and developer liquidity scrutiny increase refinancing and completion risk.
• Portfolio fit: Real estate is outside Longsheng's chemical-core competencies, implying execution and margin risks versus chemical operations.

Strategic choices and KPIs to monitor for real estate:

NEV chemical applications: current status and market dynamics:

Implications for NEV chemical applications as Question Marks/Dogs:

• High-growth market fit: Total addressable market (TAM) expanding rapidly, with global EV penetration and battery demand underpinning >20% CAGR.
• Low current share: Contribution <2% places the segment in a low-share quadrant requiring outsized investment to scale.
• R&D and commercialization risk: Higher-than-average R&D intensity (~10-15% projected) plus long qualification cycles in automotive supply chains.
• Competitive landscape: Must contend with incumbent specialty chemical giants (BASF, Evonik) with established supply contracts, scale, and certification capabilities.

Strategic options and measurable milestones for NEV chemicals:

Quantitative risk/return snapshot (illustrative):

Recommended monitoring dashboard (KPIs to report quarterly):

• Segment revenues and % of total revenue
• Segment gross margin and margin delta vs. prior quarter
• Pre-sale funds and cash conversion days for real estate
• Project IRR and completion timelines (real estate)
• R&D spend, prototype qualification status, and signed offtake agreements (NEV chemicals)
• Net debt, liquidity headroom, and covenant compliance

Zhejiang Longsheng Group Co.,Ltd (600352.SS) - BCG Matrix Analysis: Dogs

The Automotive parts business is a marginal segment contributing 1.23% to total group revenue as of H1 2025, with half-year revenue of 79.99 million CNY. The global auto parts market CAGR of 2.1% contrasts with Longsheng's limited scale, preventing cost efficiencies and competitive pricing. The segment operates in a low-margin, highly competitive environment and lacks a dominant market share, producing negligible synergy with the core chemical operations.

The Basic inorganic chemicals segment contributed 5.08% of group revenue, reporting approximately 330.36 million CNY in the most recent half-year results. Domestic oversupply and commodity-like dynamics have constrained pricing power, compressing margins. With low relative market share and participation in a mature, low-growth market, this unit consumes managerial and capital resources without clear strategic upside.

Miscellaneous 'Other Services' and operations account for roughly 1.88% of revenue, generating 122.49 million CNY in H1 2025. These fragmented lines lack alignment with the core chemical value chain and contribute minimally to the group's reported 2.07 billion CNY TTM net income. Their dispersed nature and low market presence hinder focus on higher-return segments.

Key risk drivers for these dog-quadrant units include:

• Scale disadvantage vs. larger competitors limiting unit economics (notably in automotive parts).
• Commodity oversupply and weak pricing power in basic inorganic chemicals leading to margin erosion.
• Resource diversion and management attention consumed by fragmented 'Other' businesses with no strategic fit.
• Limited contribution to group EBITDA and potential negative impact on ROIC if retained without restructuring.

Operational and financial indicators highlighting underperformance:

• Automotive parts: H1 revenue 79.99 million CNY; contribution 1.23%; unit margin below group average.
• Basic inorganic chemicals: H1 revenue ~330.36 million CNY; contribution 5.08%; price pressure from domestic oversupply.
• Other Services: H1 revenue 122.49 million CNY; contribution 1.88%; negligible impact on 2.07 billion CNY TTM net income.

Potential management responses aligned with BCG dog treatment include targeted divestment, carve-outs, cost rationalization, or consolidation of overlapping functions to free capital and management bandwidth for Star and Cash Cow segments that drive Longsheng's core growth and profitability metrics.